Our Place Drug and Alcohol Education Services

Our Place Drug and Alcohol Education Services is a SAMHSA-registered addiction-treatment facility in New Albany, IN. The facility's programming is outpatient (Outpatient), not residential. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Our Place Drug and Alcohol Education Services

On care levels: Our Place Drug and Alcohol Education Services is an outpatient-focused program (Outpatient) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The critical pre-admission step is an independent clinical assessment that establishes ASAM 4e level-of-care recommendation. Admission at a facility whose offered level does not match the clinical assessment produces most misaligned-placement outcomes.

Insurance and payment

Payment and insurance specifics for Our Place Drug and Alcohol Education Services are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The operational prerequisite is written documentation: in-network status for your specific plan product, deductible accumulation, coinsurance rate, prior-authorization status. Admissions without these four documented carry material risk of post-admission financial disagreement.

Specialty programming

The facility's documented specialty programming includes: Adolescents. Specialty designations benefit from specific follow-up: programming hours per week, credentialed staff profile, integrated assessment protocols. Dual-diagnosis as a marketing category differs from operational specialty infrastructure.

Before you call

Three pre-admission questions for Our Place Drug and Alcohol Education Services: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Our Place Drug and Alcohol Education Services offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.